OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
Henning Bliddal, Harold Bays, Sébastien Czernichow, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 17, pp. 1573-1583
Closed Access | Times Cited: 42
Henning Bliddal, Harold Bays, Sébastien Czernichow, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 17, pp. 1573-1583
Closed Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Osteoarthritis
Su’an Tang, Changqing Zhang, Win Min Oo, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 5
Su’an Tang, Changqing Zhang, Win Min Oo, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 5
Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions
Naveed Sattar, Matthew M.Y. Lee
The Lancet Diabetes & Endocrinology (2025)
Closed Access | Times Cited: 3
Naveed Sattar, Matthew M.Y. Lee
The Lancet Diabetes & Endocrinology (2025)
Closed Access | Times Cited: 3
Effect of glucagon-like peptide-1 receptor agonists in osteoarthritis: a systematic review of pre-clinical and human studies
Jacinta Cheng, Tia Solomon, Mahnuma Mahfuz Estee, et al.
Osteoarthritis and Cartilage Open (2025), pp. 100567-100567
Open Access | Times Cited: 2
Jacinta Cheng, Tia Solomon, Mahnuma Mahfuz Estee, et al.
Osteoarthritis and Cartilage Open (2025), pp. 100567-100567
Open Access | Times Cited: 2
Obesity: Recent Advances and Future Perspectives
Miodrag Janić, Andrej Janež, Mohamed El‐Tanani, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 368-368
Open Access | Times Cited: 2
Miodrag Janić, Andrej Janež, Mohamed El‐Tanani, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 368-368
Open Access | Times Cited: 2
The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesity: a look at phase 2 and 3 pipelines
Sten Madsbad, Jens J. Holst
Expert Opinion on Investigational Drugs (2025), pp. 1-19
Open Access | Times Cited: 2
Sten Madsbad, Jens J. Holst
Expert Opinion on Investigational Drugs (2025), pp. 1-19
Open Access | Times Cited: 2
Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5-15 mg in obesity with or without type 2 diabetes: A Systematic Review of Phase 3 Clinical Trials
Akriti Singh, Awadhesh Kumar Singh, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 3, pp. 103212-103212
Closed Access | Times Cited: 2
Akriti Singh, Awadhesh Kumar Singh, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 3, pp. 103212-103212
Closed Access | Times Cited: 2
Editorial: Metabolic disorders as risk factors for osteoarthritis and targeted therapies for this pathology
Giuseppe Lisco, Hee-Geun Jo, Graziana Colaianni
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 1
Giuseppe Lisco, Hee-Geun Jo, Graziana Colaianni
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 1
Two birds with one stone — Semaglutide's impacts on obesity and knee osteoarthritis: From weight loss to pain relief
Liangbin Zhou, Songlin He, Chenzhong Li, et al.
The Innovation Medicine (2025), pp. 100110-100110
Closed Access | Times Cited: 1
Liangbin Zhou, Songlin He, Chenzhong Li, et al.
The Innovation Medicine (2025), pp. 100110-100110
Closed Access | Times Cited: 1
The potential role of GLP ‐1 receptor agonists in osteoarthritis
M P Ryan, Saige Megyeri, Wesley Nuffer, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2025)
Closed Access | Times Cited: 1
M P Ryan, Saige Megyeri, Wesley Nuffer, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2025)
Closed Access | Times Cited: 1
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access | Times Cited: 1
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access | Times Cited: 1
Associations of metabolic status with all-cause mortality among individuals with osteoarthritis: A prospective cohort study
Hao Yang, Muhui Zeng, T. Fan, et al.
Journal of Orthopaedic Translation (2025) Vol. 51, pp. 207-217
Open Access | Times Cited: 1
Hao Yang, Muhui Zeng, T. Fan, et al.
Journal of Orthopaedic Translation (2025) Vol. 51, pp. 207-217
Open Access | Times Cited: 1
Rheumatology: What You May Have Missed in 2024
Brandon Blau, Lisa A. Mandl
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 1
Brandon Blau, Lisa A. Mandl
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 1
Brève : Gonalgie soulagée après antiinflammatoire et perte de poids ?
Yann-Mickael Dalmat
Option/Bio (2025) Vol. 36, Iss. 699-700, pp. 11-11
Closed Access
Yann-Mickael Dalmat
Option/Bio (2025) Vol. 36, Iss. 699-700, pp. 11-11
Closed Access
Sind GLP-1-Rezeptor-Agonisten und SGLT2-Inhibitoren auch im höheren Lebensalter geeignet?
Svea Stüdemann, Stefan Engeli
Adipositas - Ursachen Folgeerkrankungen Therapie (2025) Vol. 19, Iss. 01, pp. 39-57
Closed Access
Svea Stüdemann, Stefan Engeli
Adipositas - Ursachen Folgeerkrankungen Therapie (2025) Vol. 19, Iss. 01, pp. 39-57
Closed Access
Advances in GLP-1 receptor agonists for pain treatment and their future potential
Yongtao He, Biao Xu, Mengna Zhang, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Yongtao He, Biao Xu, Mengna Zhang, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment
Richard Salvador, Carla Moutinho, Carla Silva, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 399-399
Open Access
Richard Salvador, Carla Moutinho, Carla Silva, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 399-399
Open Access
Obesity Management in Primary Care: A Joint Clinical Perspective and Expert Review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) - 2025
N. J. Pennings, Catherine Varney, Stephanie L. Hines, et al.
Obesity Pillars (2025), pp. 100172-100172
Open Access
N. J. Pennings, Catherine Varney, Stephanie L. Hines, et al.
Obesity Pillars (2025), pp. 100172-100172
Open Access
The promise of incretin-based pharmacotherapies for metabolic dysfunction-associated fatty liver disease
Harendran Elangovan, Jenny E. Gunton, Ming‐Hua Zheng, et al.
Hepatology International (2025)
Open Access
Harendran Elangovan, Jenny E. Gunton, Ming‐Hua Zheng, et al.
Hepatology International (2025)
Open Access
Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review
Eder Luna‐Cerón, Sireesha Reddy, Lakshmi Prasanna Vaishnavi Kattamuri, et al.
Journal of Brown Hospital Medicine (2025) Vol. 4, Iss. 2
Closed Access
Eder Luna‐Cerón, Sireesha Reddy, Lakshmi Prasanna Vaishnavi Kattamuri, et al.
Journal of Brown Hospital Medicine (2025) Vol. 4, Iss. 2
Closed Access
Vous avez de l'arthrite ? Prenez un antidiabétique !
Jean-Marie Manus
Revue Francophone des Laboratoires (2025) Vol. 2025, Iss. 571, pp. 10-10
Closed Access
Jean-Marie Manus
Revue Francophone des Laboratoires (2025) Vol. 2025, Iss. 571, pp. 10-10
Closed Access
The Current and Changing Role of Glucagon-like Peptide-1 Receptor Agonists in Knee Osteoarthritis
Anne D. Holleman, Jeffrey N. Katz
Osteoarthritis and Cartilage Open (2025), pp. 100611-100611
Open Access
Anne D. Holleman, Jeffrey N. Katz
Osteoarthritis and Cartilage Open (2025), pp. 100611-100611
Open Access
Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States
John W. Ostrominski, Janinne Ortega-Montiel, Helen Tesfaye, et al.
Annals of Internal Medicine (2025)
Closed Access
John W. Ostrominski, Janinne Ortega-Montiel, Helen Tesfaye, et al.
Annals of Internal Medicine (2025)
Closed Access
Availability of Cardioprotective Medications for Type 2 Diabetes in the Medicaid Program
Anil N. Makam, Logan R.J. Bailey, N. Anderson, et al.
Annals of Internal Medicine (2025)
Closed Access
Anil N. Makam, Logan R.J. Bailey, N. Anderson, et al.
Annals of Internal Medicine (2025)
Closed Access
Efficacy and Safety of GLP-1 Receptor Agonists for the Management of Knee Osteoarthritis: A Systematic Review and Meta-Analysis
Madhusudan Prasad Singh, R. L. Yadav, Alok Singh
Research Square (Research Square) (2025)
Closed Access
Madhusudan Prasad Singh, R. L. Yadav, Alok Singh
Research Square (Research Square) (2025)
Closed Access
